Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Verrica Pharmaceuticals (VRCA) Long-Term Debt Issuances (2021)

Verrica Pharmaceuticals (VRCA) has 1 years of Long-Term Debt Issuances data on record, last reported at $5.0 million in Q1 2021.

  • For Q1 2021, Long-Term Debt Issuances changed N/A year-over-year to $5.0 million; the TTM value through Dec 2021 reached $5.0 million, changed N/A, while the annual FY2023 figure was $44.1 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $5.0 million in Q1 2021 per VRCA's latest filing.
  • Across five years, Long-Term Debt Issuances topped out at $5.0 million in Q1 2021 and bottomed at $5.0 million in Q1 2021.